Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07WHN
|
||||
Former ID |
DIB016924
|
||||
Drug Name |
FASORACETAM
|
||||
Synonyms |
LAM-105; NS-105; Fasoracetam < Prop INNM >; (R)-1-[(5-Oxo-2-pyrrolidinyl)carbonyl]piperidine; (R)-5-(Piperidin-1-ylcarbonyl)pyrrolidin-2-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cognitive disorders [ICD9: 290-294, 294.0, 780.09, 780.9, 780.93; ICD10:F01-F07, F04, F05, R41.3] | Phase 3 | [545408] | ||
Structure |
Download2D MOL |
||||
Formula |
C10H16N2O2
|
||||
Canonical SMILES |
O=C([C@H]1CCC(=O)N1)N2CCCCC2
|
||||
InChI |
1S/C10H16N2O2/c13-9-5-4-8(11-9)10(14)12-6-2-1-3-7-12/h8H,1-7H2,(H,11,13)/t8-/m1/s1
|
||||
InChIKey |
GOWRRBABHQUJMX-MRVPVSSYSA-N
|
||||
CAS Number |
CAS 110958-19-5
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Glutamate receptor AMPA subtype | Target Info | Modulator | [551871] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.